Back to Journals Drug Design, Development and Therapy Volume 20 GLP-1 Receptor Agonists in Neurological Disorders: From Mechanisms to Clinical Translation Received 1 April 2026 Accepted for publication 2 June 2026 Published 12 June 2026 Volume 2026:20 613616 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Professor Anastasios Lymperopoulos Pengpeng Li, Yangyang Gao, Wei Liu Department of Neurosurgery, Xian Aerospace Hospital of Northwest University, Xian, Shanxi, 710000, Peoples Republic of China Correspondence: Pengpeng Li, Email [email protected] Wei Liu, Email [email protected] Abstract: Glucagon-like peptide-1 receptor agonists, or GLP-1RAs, have been used for years to treat type 2 diabetes and obesity
Most of us remember which was the first meal replacement product (MRP) to hit the market and this used filtrated materials in its formula
Step 3: Remove air bubbles With the needle still in the vial, gently flick the syringe barrel to move any large bubbles toward the needle end
A Randomized Controlled Pilot Study of the Food Order Behavioral Intervention in Prediabetes
Effects of GHK-Cu on skin hydration and thickness in aged skin
Can I use Frontrow glutathione supplements with my other skincare
